1 in 5 Indian men now has elevated blood sugar; obesity across genders, shows latest National Family Health Survey. Unhealthy ...
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
By Sriparna Roy May 28 (Reuters) - CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered ...
The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...
New data seems to show that GLP-1 medications like semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, ...
Experts are calling for four-day work weeks to reduce the risk of obesity, as long hours can lead to "stress-related eating" ...
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from ...
Novo Nordisk and Eli Lilly have ⁠also launched oral versions of their anti-obesity drugs in the highly competitive U.S.
Health insurance coverage increased from 41% to 60.2% ...
New Delhi, May 29 (PTI): India has witnessed a significant rise in obesity and high blood sugar levels among adults, according to findings from the National Family Health Survey-6 (NFHS-6), pointing ...